Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 30 Rectal Neoplasms 21 Esophageal Neoplasms 15 Colorectal Neoplasms 15 Pancreatic Neoplasms 12 Lung Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Prostatic Neoplasms 10 Adenocarcinoma Of Esophagus 9 Stomach Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Head and Neck Neoplasms 8 Sarcoma 7 Esophageal Squamous Cell Carcinoma 7 Neoplasms 5 Colonic Neoplasms 5 Central Nervous System Neoplasms 5 Carcinoma, Intraductal, Noninfiltrating 5 Urinary Bladder Neoplasms 4 Inflammatory Breast Neoplasms 4 Fallopian Tube Neoplasms 4 Breast Neoplasms, Male 4 Breast Carcinoma In Situ 4 Brain Neoplasms 4 Recurrence 3 Neoplasm Metastasis 3 Kidney Neoplasms 3 Glioma 3 Glioblastoma 3

Interventions

niraparib 1 Watchful Waiting 1 Surveys and Questionnaires 1 Receptors, Bombesin 1 Radiotherapy 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Radiation 1 Observation 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Gallium 1 Estramustine 1 Docetaxel 1 Diet Therapy 1 Cholecalciferol 1 Carboplatin 1 BAY 86-7548 1 Adjuvants, Pharmaceutic 1 68Ga-bombesin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostate Adenocarcinoma × Neoadjuvant Therapy × Clear all

NCT02175212 2020-11-20

AADLPC

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Phase 3 Completed

362 enrolled 17 charts

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡